This study showed that the hypermethylation-mediated repression of cell adhesion and tight junction pathways and the hypomethylation-mediated activation of the cell growth-promoting pathways, PI3K/Akt, TGF-beta and cell cycle progression, might contribute to cisplatin resistance in ovarian cancer cells. The gene discussed is PIK3CA; the disease is ovarian cancer.